Ernexa Therapeutics (ERNAW) Other Operating Expenses (2010 - 2026)

Ernexa Therapeutics (ERNAW) reported Other Operating Expenses of $2.0 million for Q1 2026, up 29.7% quarter-over-quarter from $1.6 million in Q3 2024.

Ernexa Therapeutics (ERNAW) Other Operating Expenses (2010 - 2026) Analysis & Trends

Ernexa Therapeutics has reported Other Operating Expenses for 15 years, with the latest figure at $2.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Operating Expenses changed N/A year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (up 29.7% YoY), and the FY2024 full-year result was $1.6 million, up 242.61% from the prior year.
  • Other Operating Expenses for Q1 2026 stood at $2.0 million, up from $1.6 million in the prior quarter.
  • The five-year high for Other Operating Expenses was $2.0 million in Q1 2026, with the low at $460000.0 in Q2 2023.
  • Historically, Other Operating Expenses has averaged $1.4 million across 3 years, with a median of $1.6 million in 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Ernexa Therapeutics - - -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.04 Mn
Sep 30, 2024 1.58 Mn
Jun 30, 2023 460,000.00
Jun 30, 2021 -50,000.00
Mar 31, 2021 -9.60 Mn
Dec 31, 2020 5.08 Mn
Jun 30, 2020 -3.06 Mn
Dec 31, 2019 3.52 Mn
Sep 30, 2019 1.48 Mn
Jun 30, 2019 1.81 Mn
Mar 31, 2019 1.58 Mn
Dec 31, 2018 54,000.00
Sep 30, 2018 2.19 Mn
Jun 30, 2018 2.02 Mn
Mar 31, 2018 2.05 Mn
Dec 31, 2017 -202,000.00
Sep 30, 2017 1.62 Mn
Jun 30, 2017 1.72 Mn
Mar 31, 2017 1.93 Mn
Dec 31, 2016 2.18 Mn